2020 IPO, Venture Capital and M&A Reports

2020 IPO, Venture Capital and M&A Reports

Publication

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Helping clients navigate the complex geopolitical, legal and regulatory aspects of doing business with China.
A premier corporate governance and disclosure practice providing timely, tailored and practical advice to public company clients based on in-depth experience and insight.
WilmerHale’s corporate lawyers have a long history of experience with cross-border deals involving mergers and acquisitions, public offerings and capital markets, venture capital, joint ventures and other transactions.
Helping clients launch their businesses and transform their innovative ideas into successful companies.
Globally connected lawyers counseling clients on complex business and policy matters.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
Critical industry insight and formidable strength across key practices.
We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.

WilmerHale’s annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

The 2020 IPO Report offers a detailed IPO market review and outlook, plus useful market metrics and articles on topics of interest for pre-IPO companies, including:

  • Minimizing the risks of “friends and family” programs in an IPO
  • The pros and cons of employee stock purchase plans
  • Navigating “test-the-waters” communications
  • The impact of the landmark Salzberg decision on IPO-related securities lawsuits 
  • How crowdfunding, Regulation A and Regulation D registration exemptions have expanded the pre-IPO financing toolkit
  • The ingredients of an effective insider trading policy
  • Key features of Rule 10b5-1 trading plans
  • The significance of board oversight in the wake of recent cases involving Caremark claims
  • The latest SEC guidance on audit committee best practices

The 2020 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on the following topics:

  • Important tax issues to consider in secondary sales of private company stock
  • Questions startups and IPO companies need to resolve when designing a stock incentive plan
  • The increasing impact of privacy law on startups
  • Deal term trends in VC-backed company M&A transactions and convertible note, SAFE and venture capital financings

The 2020 M&A Report provides a global M&A market review and outlook, as well as insights on the following topics:

  • Takeover defenses for public companies
  • Tips on balancing pre-closing goals with the risk of gun-jumping antitrust violations in a merger
  • Disclosure considerations in private company mergers
  • A comparison of deal terms in public and private company acquisitions
  • The impact of buy-side representation and warranty insurance on deal terms in private company sales
  • Deal term trends in VC-backed company acquisitions

Each report also includes a center spread showcasing prominent recent transactions in each area and company counsel rankings from independent sources showing WilmerHale’s preeminence as counsel in IPOs, VC financings and sales of VC-backed companies.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel